NRXP
NRX Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.86
+0.06 ▲ +3.33%
🌙 3월 13일 7:55 PM ET (한국 3/14 08:55)
$1.86
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.35 | Insider Own | 11.55% | Shs Outstand | 0.03B | Perf Week | 9.41% |
| Market Cap | 0.06B | Forward P/E | 2.68 | EPS next Y | 166.99% | Insider Trans | - | Shs Float | 0.03B | Perf Month | 2.2% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | 0.01 | Inst Own | 25.84% | Short Float | 8.73% | Perf Quarter | -15.84% |
| Income | -0.04B | P/S | 247 | EPS this Y | 56.04% | Inst Trans | 1.5% | Short Ratio | 2.52 | Perf Half Y | -35.42% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -391.21% | Short Interest | 2.46M | Perf YTD | -31.37% |
| Book/sh | -0.93 | P/C | 8.26 | EPS past 3/5Y | 68.34% - | ROE | - | 52W High | -51.56% ($3.84) | Perf Year | -10.14% |
| Cash/sh | 0.23 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 17.72% ($1.58) | Perf 3Y | -71.95% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -9.32% | Gross Margin | 42.56% | Volatility(W/M) | 5.87% 5.88% | Perf 5Y | -99.29% |
| Dividend TTM | - | EV/Sales | 260.46 | Sales Y/Y TTM | - | Oper. Margin | -6292.98% | ATR (14) | 0.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.29 | EPS Q/Q | -79.11% | Profit Margin | -15727.69% | RSI (14) | 49.1 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.29 | Sales Q/Q | - | SMA20 | 2.24% ($1.82) | Beta | 1.96 | Target Price | $38 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -8.03% ($2.02) | Rel Volume | 0.36 | Prev Close | $1.8 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | -1236.63% -96.02% | SMA200 | -29.36% ($2.63) | Avg Volume(3M) | 0.98M | Price | $1.86 |
| IPO | 2017/12/4 | Option/Short | Yes/Yes | Trades | 1185 | Volume | 350,282 | Change | 3.33% |
뉴스 로딩 중...